Spots Global Cancer Trial Database for microarray analysis
Every month we try and update this database with for microarray analysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma | NCT00055640 | Lymphoma | rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... microarray anal... | 18 Years - | Case Comprehensive Cancer Center | |
| Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia | NCT01229956 | Leukemia | DNA methylation... gene expression... microarray anal... reverse transcr... laboratory biom... | 1 Year - 18 Years | Children's Oncology Group | |
| Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma | NCT00055640 | Lymphoma | rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... microarray anal... | 18 Years - | Case Comprehensive Cancer Center | |
| Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia | NCT00896766 | Leukemia | loss of heteroz... microarray anal... polymorphism an... tumor replicati... | 1 Year - 21 Years | Children's Oncology Group | |
| Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | NCT01231399 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Stage IV Esopha... Stage IV Gastri... | fluorouracil leucovorin calc... oxaliplatin everolimus laboratory biom... immunohistochem... microarray anal... | 19 Years - | City of Hope Medical Center | |
| Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | NCT00057798 | Lung Cancer | gemcitabine hyd... vinorelbine dit... cytogenetic ana... loss of heteroz... microarray anal... conventional su... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45 | NCT00914043 | Breast Cancer Fatigue | gene expression... microarray anal... polymerase chai... polymorphism an... reverse transcr... biologic sample... enzyme-linked i... laboratory biom... fatigue assessm... | - | NSABP Foundation Inc | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast | NCT00898937 | Breast Cancer | microarray anal... breast biopsy | 18 Years - | Georgetown University | |
| Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | NCT00057798 | Lung Cancer | gemcitabine hyd... vinorelbine dit... cytogenetic ana... loss of heteroz... microarray anal... conventional su... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy | NCT00897299 | Breast Cancer Estrogen Recept... Her-2 Pgr | microarray anal... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer | NCT00899548 | Breast Cancer | DNA methylation... microarray anal... polymerase chai... laboratory biom... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors | NCT01544569 | Kidney Cancer | DNA analysis fluorescence in... gene expression... gene mapping microarray anal... polymerase chai... protein express... laboratory biom... medical chart r... | - 1 Year | Children's Oncology Group | |
| Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer | NCT00080860 | Breast Cancer | microarray anal... immunohistochem... conventional su... lymphangiograph... radionuclide im... sentinel lymph ... technetium Tc 9... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Changes in DNA After Radiation Therapy in Patients With Prostate Cancer | NCT00899912 | Prostate Cancer | microarray anal... diagnostic labo... | 18 Years - | Radiation Therapy Oncology Group | |
| Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | NCT00088829 | Breast Cancer | paclitaxel microarray anal... biopsy neoadjuvant the... Paclitaxel | 18 Years - | Georgetown University | |
| Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | NCT00379509 | Breast Cancer | lapatinib ditos... TdT-mediated dU... gene expression... microarray anal... immunohistochem... biopsy radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer | NCT00404326 | Cervical Cancer | Hydralazine and... Punch biopsy of... | 18 Years - 70 Years | National Institute of Cancerología | |
| Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma | NCT01366157 | Lymphoma | microarray anal... protein express... immunohistochem... laboratory biom... | - 21 Years | Children's Oncology Group | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers | NCT01139983 | Sarcoma | DNA analysis RNA analysis fluorescence in... microarray anal... polymerase chai... reverse transcr... laboratory biom... | - | Children's Oncology Group | |
| Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma | NCT00567229 | Multiple Myelom... | rituximab lenalidomide microarray anal... flow cytometry laboratory biom... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia | NCT01434329 | Leukemia | DNA methylation... gene expression... microarray anal... laboratory biom... medical chart r... | 18 Years - | SWOG Cancer Research Network | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia | NCT01505699 | Leukemia | RNA analysis cytogenetic ana... microarray anal... laboratory biom... | 15 Years - 65 Years | Eastern Cooperative Oncology Group | |
| Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer | NCT00404326 | Cervical Cancer | Hydralazine and... Punch biopsy of... | 18 Years - 70 Years | National Institute of Cancerología | |
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer | NCT00899704 | Head and Neck C... | microarray anal... allele-specific... diagnostic labo... | - | Alliance for Clinical Trials in Oncology | |
| DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT00899366 | Leukemia | microarray anal... mutation analys... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma | NCT00691652 | Lymphoma | rituximab clofarabine DNA methylation... gene expression... microarray anal... polymerase chai... high performanc... laboratory biom... | 18 Years - 89 Years | OHSU Knight Cancer Institute | |
| DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia | NCT00897936 | Leukemia | DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer | NCT01119573 | Endometrial Can... | RNA analysis microarray anal... reverse transcr... laboratory biom... | - | National Cancer Institute (NCI) | |
| Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment | NCT00538291 | Colorectal Canc... | cetuximab capecitabine gene expression... microarray anal... polymorphism an... reverse transcr... immunohistochem... | 18 Years - | City of Hope Medical Center | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Genetic Study of Familial Factors in Patients With Colon Cancer | NCT00055848 | Colorectal Canc... | cytogenetic ana... gene mapping microarray anal... | - 70 Years | Alliance for Clinical Trials in Oncology | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT01055301 | Multiple Myelom... Plasma Cell Mye... | bortezomib cisplatin cyclophosphamid... dexamethasone doxorubicin hyd... etoposide lenalidomide melphalan thalidomide gene expression... microarray anal... laboratory biom... autologous-auto... | 18 Years - 65 Years | SWOG Cancer Research Network | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Microarray Analysis of Gene Expression in Prostate Tissues | NCT00186368 | Prostate Cancer | 18 Years - | Stanford University | ||
| Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202 | NCT00990873 | Lung Cancer | gene expression... microarray anal... reverse transcr... laboratory biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | NCT00486356 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Liver Cancer Unspecified Adu... | capecitabine carboplatin epirubicin hydr... microarray anal... polymorphism an... pharmacological... | 18 Years - 120 Years | University of Nebraska | |
| Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma | NCT01149850 | Giant Cell Glio... Glioblastoma Gliosarcoma | bevacizumab temozolomide laboratory biom... immunohistochem... microarray anal... DNA methylation... | 70 Years - | Jonsson Comprehensive Cancer Center | |
| S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT01055301 | Multiple Myelom... Plasma Cell Mye... | bortezomib cisplatin cyclophosphamid... dexamethasone doxorubicin hyd... etoposide lenalidomide melphalan thalidomide gene expression... microarray anal... laboratory biom... autologous-auto... | 18 Years - 65 Years | SWOG Cancer Research Network | |
| Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | NCT00897247 | Malignant Mesot... Pulmonary Compl... | microarray anal... protein express... proteomic profi... laboratory biom... | 25 Years - 80 Years | Barbara Ann Karmanos Cancer Institute | |
| A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma | NCT00661336 | Melanoma (Skin) | buthionine sulf... melphalan microarray anal... high performanc... laboratory biom... pharmacological... biopsy | 18 Years - | Duke University | |
| Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia | NCT01421875 | Leukemia | DNA methylation... RNA analysis gene expression... microarray anal... nucleic acid se... laboratory biom... | 61 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma | NCT01366170 | Lymphoma | microarray anal... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... mass spectromet... | - 20 Years | Children's Oncology Group | |
| Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia | NCT01653613 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom... | 16 Years - 39 Years | National Cancer Institute (NCI) | |
| Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer | NCT00070278 | Breast Cancer | cyclophosphamid... epirubicin hydr... gemcitabine hyd... paclitaxel comparative gen... microarray anal... mutation analys... conventional su... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | NCT00470184 | Esophageal Canc... | capecitabine oxaliplatin gene expression... microarray anal... reverse transcr... adjuvant therap... biopsy conventional su... neoadjuvant the... quality-of-life... radiation thera... | 18 Years - | Roswell Park Cancer Institute | |
| Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | NCT00900289 | Ovarian Cancer | DNA methylation... microarray anal... polymerase chai... immunohistochem... laboratory biom... | 18 Years - | Cancer Research UK, Glasgow | |
| Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer | NCT00467129 | Colorectal Canc... | microarray anal... mutation analys... polymerase chai... polymorphism an... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
| S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT01055301 | Multiple Myelom... Plasma Cell Mye... | bortezomib cisplatin cyclophosphamid... dexamethasone doxorubicin hyd... etoposide lenalidomide melphalan thalidomide gene expression... microarray anal... laboratory biom... autologous-auto... | 18 Years - 65 Years | SWOG Cancer Research Network | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies | NCT00897663 | Brain and Centr... | gene expression... microarray anal... protein express... diagnostic labo... immunohistochem... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia | NCT00611000 | Colorectal Canc... | folic acid DNA methylation... gene expression... microarray anal... polymorphism an... laboratory biom... | 40 Years - 72 Years | National Cancer Institute (NCI) | |
| Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor | NCT01118078 | Clear Cell Sarc... Recurrent Wilms... Rhabdoid Tumor ... Stage I Wilms T... Stage II Wilms ... Stage III Wilms... Stage IV Wilms ... Stage V Wilms T... | DNA methylation... gene expression... microarray anal... reverse transcr... diagnostic labo... | - 16 Years | Children's Oncology Group | |
| Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma | NCT00567229 | Multiple Myelom... | rituximab lenalidomide microarray anal... flow cytometry laboratory biom... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer | NCT00897143 | Lung Cancer Metastatic Canc... | microarray anal... mutation analys... flow cytometry immunologic tec... | - | Case Comprehensive Cancer Center | |
| Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations | NCT00700778 | BRCA1 Mutation Breast Cancer | recombinant hum... microarray anal... immunohistochem... laboratory biom... needle biopsy | 20 Years - 40 Years | Fox Chase Cancer Center | |
| Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma | NCT01149850 | Giant Cell Glio... Glioblastoma Gliosarcoma | bevacizumab temozolomide laboratory biom... immunohistochem... microarray anal... DNA methylation... | 70 Years - | Jonsson Comprehensive Cancer Center | |
| Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | NCT00900289 | Ovarian Cancer | DNA methylation... microarray anal... polymerase chai... immunohistochem... laboratory biom... | 18 Years - | Cancer Research UK, Glasgow | |
| Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia | NCT00769327 | Leukemia | imatinib mesyla... nilotinib cytogenetic ana... fluorescence in... microarray anal... mutation analys... polymerase chai... polymorphism an... laboratory biom... | 18 Years - 120 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030 | NCT00899535 | Lung Cancer | DNA analysis RNA analysis microarray anal... mutation analys... polymorphism an... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia | NCT00897936 | Leukemia | DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples | NCT00629577 | Cervical Cancer Precancerous Co... | microarray anal... flow cytometry biopsy colposcopy | 19 Years - | British Columbia Cancer Agency | |
| S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911 | NCT00896922 | Lymphoma | microarray anal... immunohistochem... laboratory biom... | 16 Years - 120 Years | SWOG Cancer Research Network | |
| Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia | NCT01653613 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom... | 16 Years - 39 Years | National Cancer Institute (NCI) | |
| Biomarkers in Tissue Samples From Young Patients With Liver Cancer | NCT01336881 | Childhood Hepat... Stage I Childho... Stage II Childh... Stage III Child... Stage IV Childh... | RNA analysis gene expression... microarray anal... nucleic acid se... diagnostic labo... | - 16 Years | Children's Oncology Group | |
| Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia | NCT00898261 | Leukemia | microarray anal... reverse transcr... flow cytometry | 15 Years - 65 Years | Eastern Cooperative Oncology Group | |
| Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes | NCT00382200 | Myelodysplastic... | decitabine tretinoin DNA methylation... cytogenetic ana... microarray anal... flow cytometry immunohistochem... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy | NCT00897299 | Breast Cancer Estrogen Recept... Her-2 Pgr | microarray anal... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17 | NCT00897065 | Breast Cancer | microarray anal... polymerase chai... protein express... diagnostic labo... fluorescent ant... immunohistochem... immunologic tec... | - | National Cancer Institute (NCI) | |
| Temozolomide in Treating Patients With Invasive Pituitary Tumors | NCT00601289 | Brain and Centr... | temozolomide DNA methylation... microarray anal... protein express... proteomic profi... laboratory biom... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Studying Gene Expression and Location in Samples From Patients With Brain Tumors | NCT01585389 | Brain and Centr... | gene expression... genetic linkage... microarray anal... immunohistochem... laboratory biom... | - | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
